Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder
PV Magalhaes, F Kapczinski, AA Nierenberg, T Deckersbach, D Weisinger, S Dodd, M Berk
Acta Psychiatrica Scandinavica | WILEY | Published : 2012
The Systematic Treatment Enhancement Program for Bipolar Disorder was funded by the National Institute of Mental Health, which had no role in drafting or analyzing and preparing this manuscript. The data set was obtained from the National Institutes of Mental Health by a request from Prof. Berk that was specifically approved by Barwon Health's Human Research Ethics Committee. STEP-BD was registered at clinicaltrials.gov with the identifier NCT00012558. Dr. Magalhaes is supported by the National Institute for Translational Medicine, Brazil.Prof. Kapczinski has received grant/research support from Astra-Zeneca, Eli Lilly, the Janssen-Cilag, Servier, CNPq, CAPES, NARSAD, and the Stanley Medical Research Institute; has been a member of the speakers' boards for Astra-Zeneca, Eli Lilly, Janssen, and Servier; and has served as a consultant for Servier. Prof. Berk has received research support from Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma, Servier. He has been a speaker for Speakers: Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi Synthelabo, Servier, Solvay, and Wyeth. He has been a consultant for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, and Servier.As of September 2, 2009, Dr Nierenberg is a consultant for Appliance Computing (Mindsite), BrainCells, Brandeis University, PGx Health, Shire, Schering-Plough, Targacept, and Takeda; has received grant/research support from National Institute of Mental Health, Pamlab, Pfizer, and Shire; has received honoraria from Belvior Publishing, University of Texas Southwestern Dallas, Hillside Hospital, American Drug Utilization Review, American Society for Clinical Psychopharmacology, Baystate Medical Center, Columbia University, IMEDEX, MJ Consulting, New York State, MBL Publishing, Physicians Postgraduate Press, SUNY Buffalo, University of Wisconsin, and the University of Pisa; is on the advisory boards of Appliance Computing, BrainCells, Eli Lilly, and Takeda; is a stock shareholder of Appliance Computing and BrainCells; and, through Massachusetts General Hospital, owns copyrights to the Clinical Positive Affect Scale and the MGH Structured Clinical Interview for the Montgomery-Asberg Depression Rating Scale exclusively licensed to the MGH Clinical Trials Network and Institute.